QVA149 Articles
Forest launches COPD product Tudorza in USA
12 December 2012
News briefs: Italy lifts hold on Novartis vaccines; files for QVA149 in Japan; Mylan patent settlement
11 November 2012
Novartis/Vectura's QVA149 is filed as a treatment for COPD in Europe; Certican EU approval
26 October 2012
New data from Novartis on QVA149 and Seebri Breezhaler at ERS
3 September 2012
Credit Suisse focus on new drugs for COPD
19 August 2012
Showing 1-7 of 7 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
